228 related articles for article (PubMed ID: 31313060)
41. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
42. Re-Irradiation with Stereotactic Radiosurgery/Radiotherapy for Recurrent High-Grade Gliomas: Improved Survival in the Modern Era.
Gigliotti MJ; Hasan S; Karlovits SM; Ranjan T; Wegner RE
Stereotact Funct Neurosurg; 2018; 96(5):289-295. PubMed ID: 30404102
[TBL] [Abstract][Full Text] [Related]
43. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
[TBL] [Abstract][Full Text] [Related]
44. Image-Guided, Linac-Based, Surgical Cavity-Hypofractionated Stereotactic Radiotherapy in 5 Daily Fractions for Brain Metastases.
Soliman H; Myrehaug S; Tseng CL; Ruschin M; Hashmi A; Mainprize T; Spears J; Das S; Yang V; da Costa L; Maralani P; Heyn C; Atenafu EG; Sahgal A
Neurosurgery; 2019 Nov; 85(5):E860-E869. PubMed ID: 31173150
[TBL] [Abstract][Full Text] [Related]
45. Fractionated stereotactic radiotherapy for metastatic brain tumors that recurred after gamma knife radiosurgery results in acceptable toxicity and favorable local control.
Miyakawa A; Shibamoto Y; Takemoto S; Serizawa T; Otsuka S; Hirai T
Int J Clin Oncol; 2017 Apr; 22(2):250-256. PubMed ID: 27826659
[TBL] [Abstract][Full Text] [Related]
46. Postoperative hypofractionated stereotactic brain radiation (HSRT) for resected brain metastases: improved local control with higher BED
Kumar AMS; Miller J; Hoffer SA; Mansur DB; Coffey M; Lo SS; Sloan AE; Machtay M
J Neurooncol; 2018 Sep; 139(2):449-454. PubMed ID: 29749569
[TBL] [Abstract][Full Text] [Related]
47. Outcomes following stereotactic radiosurgery for small to medium-sized brain metastases are exceptionally dependent upon tumor size and prescribed dose.
Moraes FY; Winter J; Atenafu EG; Dasgupta A; Raziee H; Coolens C; Millar BA; Laperriere N; Patel M; Bernstein M; Kongkham P; Zadeh G; Conrad T; Chung C; Berlin A; Shultz DB
Neuro Oncol; 2019 Feb; 21(2):242-251. PubMed ID: 30265328
[TBL] [Abstract][Full Text] [Related]
48. Extent of perilesional edema differentiates radionecrosis from tumor recurrence following stereotactic radiosurgery for brain metastases.
Leeman JE; Clump DA; Flickinger JC; Mintz AH; Burton SA; Heron DE
Neuro Oncol; 2013 Dec; 15(12):1732-8. PubMed ID: 24243914
[TBL] [Abstract][Full Text] [Related]
49. Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Association for Radiation Oncology (DEGRO).
Rogers S; Baumert B; Blanck O; Böhmer D; Boström J; Engenhart-Cabillic R; Ermis E; Exner S; Guckenberger M; Habermehl D; Hemmatazad H; Henke G; Lohaus F; Lux S; Mai S; Minasch D; Rezazadeh A; Steffal C; Temming S; Wittig A; Zweifel C; Riesterer O; Combs SE
Strahlenther Onkol; 2022 Oct; 198(10):919-925. PubMed ID: 36006436
[TBL] [Abstract][Full Text] [Related]
50. Treatment of Large Brain Metastases With Stereotactic Radiosurgery.
Zimmerman AL; Murphy ES; Suh JH; Vogelbaum MA; Barnett GH; Angelov L; Ahluwalia M; Reddy CA; Chao ST
Technol Cancer Res Treat; 2016 Feb; 15(1):186-95. PubMed ID: 25633136
[TBL] [Abstract][Full Text] [Related]
51. FSRT vs. SRS in Brain Metastases-Differences in Local Control and Radiation Necrosis-A Volumetric Study.
Putz F; Weissmann T; Oft D; Schmidt MA; Roesch J; Siavooshhaghighi H; Filimonova I; Schmitter C; Mengling V; Bert C; Frey B; Lettmaier S; Distel LV; Semrau S; Fietkau R
Front Oncol; 2020; 10():559193. PubMed ID: 33102223
[No Abstract] [Full Text] [Related]
52. Fractionated stereotactic radiotherapy using CyberKnife for the treatment of large brain metastases: a dose escalation study.
Murai T; Ogino H; Manabe Y; Iwabuchi M; Okumura T; Matsushita Y; Tsuji Y; Suzuki H; Shibamoto Y
Clin Oncol (R Coll Radiol); 2014 Mar; 26(3):151-8. PubMed ID: 24332223
[TBL] [Abstract][Full Text] [Related]
53. Efficacy of pre-operative stereotactic radiosurgery followed by surgical resection and correlative radiobiological analysis for patients with 1-4 brain metastases: study protocol for a phase II trial.
Huff WX; Agrawal N; Shapiro S; Miller J; Kulwin C; Shah M; Savage JJ; Payner T; Vortmeyer A; Watson G; Dey M
Radiat Oncol; 2018 Dec; 13(1):252. PubMed ID: 30572923
[TBL] [Abstract][Full Text] [Related]
54. Survival and intracranial control of patients with 5 or more brain metastases treated with gamma knife stereotactic radiosurgery.
Raldow AC; Chiang VL; Knisely JP; Yu JB
Am J Clin Oncol; 2013 Oct; 36(5):486-90. PubMed ID: 22706180
[TBL] [Abstract][Full Text] [Related]
55. Timing of Adjuvant Fractionated Stereotactic Radiosurgery Affects Local Control of Resected Brain Metastases.
Roth O'Brien DA; Poppas P; Kaye SM; Mahase SS; An A; Christos PJ; Liechty B; Pisapia D; Ramakrishna R; Wernicke AG; Knisely JPS; Pannullo S; Schwartz TH
Pract Radiat Oncol; 2021; 11(3):e267-e275. PubMed ID: 33578001
[TBL] [Abstract][Full Text] [Related]
56. Local progression and pseudo progression after single fraction or fractionated stereotactic radiotherapy for large brain metastases. A single centre study.
Wiggenraad R; Verbeek-de Kanter A; Mast M; Molenaar R; Kal HB; Lycklama à Nijeholt G; Vecht C; Struikmans H
Strahlenther Onkol; 2012 Aug; 188(8):696-701. PubMed ID: 22722818
[TBL] [Abstract][Full Text] [Related]
57. Predicting the Risk of Developing New Cerebral Lesions After Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy for Brain Metastases from Renal Cell Carcinoma.
Rades D; Dziggel L; Blanck O; Gebauer N; Bartscht T; Schild SE
Anticancer Res; 2018 May; 38(5):2973-2976. PubMed ID: 29715126
[TBL] [Abstract][Full Text] [Related]
58. Repeated stereotactic radiosurgery for patients with progressive brain metastases.
Minniti G; Scaringi C; Paolini S; Clarke E; Cicone F; Esposito V; Romano A; Osti M; Enrici RM
J Neurooncol; 2016 Jan; 126(1):91-97. PubMed ID: 26369769
[TBL] [Abstract][Full Text] [Related]
59. HFSRT of the resection cavity in patients with brain metastases.
Specht HM; Kessel KA; Oechsner M; Meyer B; Zimmer C; Combs SE
Strahlenther Onkol; 2016 Jun; 192(6):368-76. PubMed ID: 26964777
[TBL] [Abstract][Full Text] [Related]
60. Tumor Cavity Recurrence after Stereotactic Radiosurgery of Surgically Resected Brain Metastases: Implication of Deviations from Contouring Guidelines.
McDermott DM; Hack JD; Cifarelli CP; Vargo JA
Stereotact Funct Neurosurg; 2019; 97(1):24-30. PubMed ID: 30763944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
